TABLE 5.
Prevalence of anti-CMV antibodies by SCT status, ethnicity, and sex
| Category | No. of patients positive for CMV antibody/no. tested (%)
|
P value for post-SCT vs pre-SCT | ||
|---|---|---|---|---|
| Non-SCT and auto-SCT | Pre-allo-SCT | Post-allo-SCTa | ||
| Ethnicity | ||||
| White | 770/987 (78.0) | 621/846 (73.4) | 285/327 (87.2) | <0.001 |
| Black | 129/152 (84.9) | 41/48 (85.4) | 23/26 (88.5) | NSb |
| Asian | 54/64 (84.4) | 54/58 (93.1) | 28/28 (100) | NS |
| Hispanic | 188/215 (87.4) | 146/179 (81.6) | 77/85 (90.6) | 0.059 |
| Sex | ||||
| Male | 600/781 (76.8) | 494/669 (73.8) | 240/275 (87.3) | <0.001 |
| Female | 541/637 (84.9) | 368/462 (79.7) | 173/191 (90.6) | <0.001 |
| P value | <0.001 | 0.024 | NS | |
| Total | 1141/1,418 (80.5) | 862/1,131 (76.2) | 413/466 (88.6) | <0.001 |
a
Most patients in this category were tested for CMV antibody before SCT.
b
NS, not significant.